SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* Shell William (Last) (First) (Middle) C/O TARGETED MEDICAL PHARMA, INC. 2980 BEVERLY GLEN CIRCLE, SUITE 301 (Street) LOS ANGELES CA 90077 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol Targeted Medical Pharma, Inc. [ TRGM ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director X 10% Owner X Officer (give title below) Other (specify below) CEO & Chief Scientific Officer
	3. Date of Earliest Transaction (Month/Day/Year) 09/11/2013
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person X Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $.001 par value per share	09/13/2013		S		2,000	D	$0.84(5)	208,000	I	By wife
Common Stock, $.001 par value per share	09/11/2013		W		5,303,795	A	$0	5,370,054	I	By trust(1)
Common Stock, $.001 par value per share	09/11/2013		W		300,000	A	$0	720,799	I	By trust(2)
Common Stock, $.001 par value per share	09/11/2013		W		3,422,748	A	$0	3,422,748	I	By trust(3)
Common Stock, $.001 par value per share	09/11/2013		W		8,342,748	D	$0	722,485	I	By trust(4)
Common Stock, $.001 par value per share	09/11/2013		W		99,000	D	$0	0	D
Common Stock, $.001 par value per share	09/11/2013		W		584,795	D	$0	66,259	I	By trust(1)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

1. Name and Address of Reporting Person* Shell William (Last) (First) (Middle) C/O TARGETED MEDICAL PHARMA, INC. 2980 BEVERLY GLEN CIRCLE, SUITE 301 (Street) LOS ANGELES CA 90077 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer X Director X 10% Owner X Officer (give title below) Other (specify below) CEO & Chief Scientific Officer

1. Name and Address of Reporting Person* Elizabeth Charuvastra & William Shell Family Trust (Last) (First) (Middle) 3048 NICADA DRIVE (Street) LOS ANGELES CA 90077 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* William Shell Survivor's Trust (Last) (First) (Middle) 3048 NICADA DRIVE (Street) LOS ANGELES CA 90077 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Elizabeth Charuvastra Marital Trust (Last) (First) (Middle) 3048 NICADA DRIVE (Street) LOS ANGELES CA 90077 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

Explanation of Responses:

1. Common stock and warrants are held by William Shell Survivor's Trust.

2. Common stock held by Elizabeth Charuvastra Exemption Trust. William E. Shell is filing on behalf of the Elizabeth Charuvastra Exemption Trust and disclaims any and all pecuniary interest in the Elizabeth Charuvastra Exemption Trust.

3. Common stock held by Elizabeth Charuvastra Marital Trust

4. Common stock held by Elizabeth Charuvastra & William Shell Family Trust. Includes 216,408 shares of common stock beneficially owned by family and friends of Dr. Shell over which the Elizabeth Charuvastra and William Shell Family Trust dated July 27, 2006 and Amended September 29, 2006 maintains voting and dispositive control.

5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.77 to $0.90 per share.

Remarks:

As a result of the transactions described in this Form 4, the Elizabeth Charuvastra & William Shell Family Trust is no longer a 10% Owner and is therefore no longer subject to Section 16.

	/s/ William E. Shell	09/17/2013
	Elizabeth Charuvastra and William Shell Family Trust dated 9/26/2008,by /s/ William E. Shell, Trustee	09/17/2013
	William Shell Survivor's Trust, by /s/ William E. Shell	09/17/2013
	Elizabeth Charuvastra Marital Trust, by /s/ William E. Shell	09/17/2013
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.